文献速递自身免疫性与大疱性皮肤病

胶原XVII C端加工诱导线性IgA皮病自身抗体新表位

C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies.
PubMed 文献 · J Invest Dermatol · 2017-08-24

本研究探讨胶原XVII(COL17)C端加工是否诱导线性IgA皮病(LAD)自身抗体新表位。制备靶向COL17第15胶原域的单克隆抗体hC17-ect15,其特性类似LAD自身抗体,优先与C端缺失(至682氨基酸)的重组COL17反应,LAD自身抗体亦如此。将hC17-ect15被动转移至表达人COL17的转基因小鼠未诱导水疱病,提示靶向新表位的抗体并非总是致病。

要点

  • COL17的C端加工可在第15胶原域形成LAD自身抗体识别的新表位。
  • LAD自身抗体与C端缺失的COL17重组蛋白反应增强。
  • 靶向新表位的抗体被动转移至人COL17转基因小鼠未诱发水疱病。

核心结论

  • COL17的C端加工诱导动态结构改变并在第15胶原域形成LAD自身抗体新表位。
  • 靶向新表位的抗体并不总是具有致病性。

研究设计与样本

  • 制备靶向COL17第15胶原域的单克隆抗体hC17-ect15,并与LAD自身抗体比较反应性。
  • 使用C端缺失(至682氨基酸)的重组COL17进行抗体结合分析。
  • 将hC17-ect15被动转移至表达人COL17的转基因小鼠观察是否诱发水疱病。

主要发现

  • hC17-ect15表现出与LAD自身抗体相似的特性。
  • hC17-ect15优先与C端缺失(至682氨基酸)的重组COL17反应。
  • LAD自身抗体也与C端缺失的COL17反应。
  • 被动转移hC17-ect15至人COL17转基因小鼠未诱导水疱病。

临床怎么用

  • 提示LAD自身抗体可靶向COL17 C端加工后形成的新表位。
  • 靶向新表位的抗体存在不一定足以致病,需结合其他因素评估。

局限性

  • 被动转移实验仅使用一种单克隆抗体hC17-ect15,未涵盖LAD自身抗体全部多样性。
  • 未明确C端加工的具体酶或生理条件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Transmembrane collagen XVII (COL17) is a hemidesmosomal component of basal keratinocytes that can be targeted by autoantibodies in autoimmune blistering disorders, including linear IgA dermatosis (LAD). COL17 can be physiologically cleaved within the juxtamembranous extracellular NC16A domain, and LAD autoantibodies preferentially react with the processed ectodomains, indicating that the processing induces neoepitopes. However, the details of how neoepitopes develop have not been elucidated. In this study, we show that C-terminal processing of COL17 also plays a role in inducing neoepitopes for LAD autoantibodies. First, the mAb hC17-ect15 targeting the 15th collagenous domain of COL17 was produced, which showed characteristics similar to LAD autoantibodies. The mAbs preferentially reacted with C-terminally deleted (up to 682 amino acids) recombinant COL17, suggesting that C-terminal processing shows neoepitopes on the 15th collagenous domain. The LAD autoantibodies also react with C-terminal deleted COL17. Therefore, neoepitopes for LAD autoantibodies also develop after C-terminal processing. Finally, the passive transfer of the mAb hC17-ect15 into human COL17-expressing transgenic mice failed to induce blistering disease, suggesting that neoepitope-targeting antibodies are not always pathogenic. In summary, this study shows that C-terminal processing induces dynamic structural changes and neoepitopes for LAD autoantibodies on COL17.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Toyonaga E, Nishie W, Izumi K, et al. C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies. J Invest Dermatol. 2017. PMID: 28842325. doi:10.1016/j.jid.2017.07.831

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。